MYOTONACHOL Drug Patent Profile
✉ Email this page to a colleague
When do Myotonachol patents expire, and what generic alternatives are available?
Myotonachol is a drug marketed by Glenwood and is included in one NDA.
The generic ingredient in MYOTONACHOL is bethanechol chloride. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Myotonachol
A generic version of MYOTONACHOL was approved as bethanechol chloride by UPSHER SMITH LABS on June 1st, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MYOTONACHOL?
- What are the global sales for MYOTONACHOL?
- What is Average Wholesale Price for MYOTONACHOL?
Summary for MYOTONACHOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Patent Applications: | 1,356 |
DailyMed Link: | MYOTONACHOL at DailyMed |
US Patents and Regulatory Information for MYOTONACHOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glenwood | MYOTONACHOL | bethanechol chloride | TABLET;ORAL | 084188-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Glenwood | MYOTONACHOL | bethanechol chloride | TABLET;ORAL | 084188-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Glenwood | MYOTONACHOL | bethanechol chloride | TABLET;ORAL | 084188-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |